Evommune, Inc. EVMN

Rank #2074 · NYSE · $0.2B market cap

⚠ Going-concern flag — the auditor (BDO USA, P.C) raised substantial doubt about this company's ability to continue operating in the latest filing. Read the actual filing before drawing conclusions.

Score

34.7

P/E

-3.6

P/B

-3.12

ROE

86.0%

Op. Margin

-1000.2%

Debt Ratio

-37%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆

Poor

P/E -3.6x, P/B -3.12x. Ranks in the top 96% of the universe.

Profitability ★★☆☆☆

Average

ROE 86.0%. Ranks in the top 50% of the universe.

Safety ★★★★★

Excellent

Debt ratio -37%. Ranks in the top 6% of the universe. Under 100% is generally considered a safe level.

Growth –

No data

Not enough historical filings to compute year-over-year growth yet.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2025	$0.0B	$-0.1B	$-0.1B	$-0.1B	-1000.2	-37

← See the full screener